Overview

Eliquis Regulatory Post Marketing Surveillance

Status:
Completed
Trial end date:
2017-09-29
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to examine the safety profile of Eliquis in Korean nonvalvular atrial fibrillation patients.
Details
Lead Sponsor:
Bristol-Myers Squibb
Treatments:
Apixaban